Journal article · 2007

FDA draft guidance and health-outcomes research

Dennis A. Revicki

The Lancet, 369(9561), 540–542 · Published 1 February 2007 · DOI 10.1016/s0140-6736(07)60250-5

View at the publisherCite this paper

In brief

“FDA draft guidance and health-outcomes research” is a 2007 journal article by Dennis A. Revicki, published in The Lancet. OpenAlex counts 96 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
96
Most cited in
2016 (9)
Field-weighted impact
18.73
References
7
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Revicki, D. A. (2007). FDA draft guidance and health-outcomes research. The Lancet, 369(9561), 540–542. https://doi.org/10.1016/s0140-6736(07)60250-5

MLA 9

Revicki, Dennis A. “FDA draft guidance and health-outcomes research.” The Lancet, vol. 369, no. 9561, 2007, pp. 540–542. https://doi.org/10.1016/s0140-6736(07)60250-5.

Chicago

Revicki, Dennis A. 2007. “FDA draft guidance and health-outcomes research.” The Lancet 369 (9561): 540–542. https://doi.org/10.1016/s0140-6736(07)60250-5.

Harvard

Revicki, D. A. (2007) ‘FDA draft guidance and health-outcomes research’, The Lancet, 369(9561), pp. 540–542. doi:10.1016/s0140-6736(07)60250-5.

IEEE

D. A. Revicki, “FDA draft guidance and health-outcomes research,” The Lancet, vol. 369, no. 9561, pp. 540–542, 2007, doi: 10.1016/s0140-6736(07)60250-5.

BibTeX

@article{revicki2007draft,
  title     = {{FDA draft guidance and health-outcomes research}},
  author    = {Revicki, Dennis A.},
  journal   = {The Lancet},
  year      = {2007},
  volume    = {369},
  number    = {9561},
  pages     = {540--542},
  doi       = {10.1016/s0140-6736(07)60250-5},
  url       = {https://doi.org/10.1016/s0140-6736(07)60250-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201699
201755
201855
201944
202044
202111
202211
202322
202422
202533

Its field-weighted citation impact is 18.73: it has been cited 18.73 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • FDA draft guidance
  • health-related quality of life
  • health outcomes research
  • regulatory guidelines
  • psychometric assessment
  • conceptual framework
  • instrument development

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Revicki, D. A. (2007). FDA draft guidance and health-outcomes research. The Lancet, 369(9561), 540–542. https://doi.org/10.1016/s0140-6736(07)60250-5

How many times has this paper been cited?

96 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Dennis A. Revicki.

What is the DOI of this paper?

10.1016/s0140-6736(07)60250-5, permanently at https://doi.org/10.1016/s0140-6736(07)60250-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.